Aminosyn II 4.25
- Generic Name: amino acid injection in dextrose injection
- Brand Name: Aminosyn II 4.25% in 25% Dextrose
Aminosyn II 4.25% in 25% Dextrose (Amino Acid Injection in Dextrose Injection) side effects drug center
- Related Drugs
- injection site reactions (skin redness, inflammation, swelling, infection, or blood clots)
- flushing
- fever, and
- nausea
Aminosyn II 4.25% in 25% Dextrose Injection (amino acids) is a combination of amino acids used for central vein infusion in the prevention of nitrogen loss and negative nitrogen balance in cases where (a) the gastrointestinal tract by the oral, gastrostomy or jejunostomy route cannot or should not be used, (b) gastrointestinal absorption of nutrients is impaired or (c) metabolic requirements for protein and calories are substantially increased as with extensive burns and (d) morbidity and mortality may be reduced by replacing amino acids lost from tissue breakdown, thereby preserving tissue reserves, as in acute renal failure. Common side effects of Aminosyn II 4.25% in 25% Dextrose Injection include:
Rapid administration of Aminosyn II 4.25% in 25% Dextrose Injection may cause mental confusion and/or loss of consciousness.
The total daily dose of Aminosyn II 4.25% Injection to be infused depends on daily protein and caloric requirements and on the patient's metabolic and clinical response. Aminosyn II 4.25% may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Aminosyn II 4.25% should be used only if prescribed. Consult your doctor before breastfeeding.
Our Aminosyn II 4.25% in 25% Dextrose Injection (amino acids) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
SIDE EFFECTS
Hyperosmolar syndrome, resulting from excessively rapid administration of concentrated dextrose may cause mental confusion and/or loss of consciousness.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
Generalized flushing, fever and nausea also have been reported during peripheral infusions of amino acid solutions.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Read the entire FDA prescribing information for Aminosyn II 4.25 (Amino Acid Injection in Dextrose Injection)
© Aminosyn II 4.25 Patient Information is supplied by Cerner Multum, Inc. and Aminosyn II 4.25 Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.